GNLX Competitors & Alternatives
Compare Genelux Corporation Common Stock with similar stocks in the same industry
Biotechnology
GNLX
Main Stock$2.99
Tradestie Score
56
Market Cap
$166.20M
Revenue Growth
-1.0%
Analyst Upside
+485.3%
Top Competitors
237 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
AVTX
Avalo Therapeutics, Inc. Common Stock
|
$18.84
|
$170.45M | - | 55 | Compare |
|
ACHV
Achieve Life Sciences, Inc.
|
$6.40
|
$158.43M | - | 60 | Compare |
|
NVCT
Nuvectis Pharma, Inc. Common Stock
|
$19.57
|
$154.27M | - | 53 | Compare |
|
CLYM
Climb Bio, Inc. Common Stock
|
$12.90
|
$133.50M | - | 57 | Compare |
|
SRZN
Surrozen, Inc. Common
|
$24.92
|
$117.07M | - | 55 | Compare |
|
STTK
Shattuck Labs, Inc. Common Stock
|
$7.05
|
$114.01M | - | 55 | Compare |
|
ANRO
Alto Neuroscience Inc.
|
$24.78
|
$110.20M | - | 58 | Compare |
|
OVID
Ovid Therapeutics Inc. Common Stock
|
$2.69
|
$97.42M | - | 55 | Compare |
|
STRO
Sutro Biopharma, Inc.
|
$30.43
|
$76.55M | - | 58 | Compare |
|
EUDA
EUDA Health Holdings Limited Ordinary Shares
|
$13.88
|
$73.94M | - | 53 | Compare |
More GNLX Analysis
Data updated: Jul 05, 2026 | Industry: Biotechnology (SIC 2834)
237 stocks in this industry